Muscle Stimulator Market (2026 - 2033) Size, Share & Trends Analysis Report By Modality (Handheld, Portable, Table Top), By Product, By Application (Pain Management, Musculoskeletal Disorder), By End-use, By Region, And Segment Forecasts

Muscle Stimulator Market Summary

The global muscle stimulator market size was valued at USD 853.3 million in 2025 and is projected to grow from USD 881.7 million in 2026 to USD 1,090.2 million by 2033, at a CAGR of 3.1% from 2026 to 2033. The North America held the largest share of 41.1% of the global market in 2025. The growth of the market is driven by the rising prevalence of chronic pain, an aging population, and the growing demand for non-invasive rehabilitation in physiotherapy and sports medicine.

Technological advancements enabling portable, wearable, and smart EMS devices for home use are further accelerating adoption. The section below outlines the key factors driving the growth of the muscle stimulator market, highlighting advancements in technology, rising demand for pain management and rehabilitation, a surge in outpatient and home-based physical therapy, and the rising incidence of sports injuries and accidents.

Market Drivers

Technological Advancements in the Muscle Stimulator Market

Technological advancements in the muscle stimulator industry are significantly driving its growth by enhancing the efficacy, convenience, and accessibility of these devices. The integration of wearable technology has made muscle stimulators more portable and discreet, allowing users to seamlessly incorporate them into their daily routines or fitness regimens. Further, smart connectivity and mobile app integration have revolutionized the user experience by enabling remote control, real-time tracking, and personalized treatment plans tailored to individual needs. For instance, in March 2023, Neuro20 Technologies Corp received FDA approval for its wearable Neuro20 PRO system, a whole-body electrical muscle stimulator suit, software, and operating system.

Rising Demand for Pain Management & Rehabilitation

The increasing prevalence of chronic pain conditions and musculoskeletal disorders is driving the demand for muscle stimulators. Patients and healthcare providers are increasingly adopting non-invasive and drug-free pain management solutions, such as electrical stimulation therapies, to reduce dependency on opioids and improve rehabilitation outcomes. Muscle stimulators are widely used for pain relief, muscle re-education, and post-surgical recovery, making them an essential component of modern rehabilitation practices. For instance, in April 2025, Zynex, Inc. highlighted the growing adoption of its NexWave device for chronic pain management, emphasizing increased demand from patients seeking non-pharmacological treatment options.

Surge in Outpatient and Home-Based Physical Therapy

The increasing shift toward outpatient care and home-based rehabilitation is increasing the adoption of portable muscle stimulator devices. The devices allow patients to continue therapy outside hospital settings, improving convenience and treatment adherence. For instance, in March 2024, Zynex announced the NexWave Electrotherapy Device as a new approach to pain management. NexWave is a safer alternative to the typical pain medication prescriptions. Pain medication consumption can cause allergic reactions, addiction, organ damage, and digestive problems, among other issues. Many patients receive pain medication as the only treatment for their pain, which has been abused by patients.

Rising incidence of sports injuries and accidents

The rising number of sports-related injuries and musculoskeletal conditions is driving the growing demand for muscle-stimulation therapies. Injuries such as ligament tears and strains, as well as post-surgical recovery cases, require effective rehabilitation solutions to restore muscle function. For instance, in March 2025, a study published by Oregon State University reported that approximately 15,000 soccer-related ACL injuries occur annually, highlighting the substantial burden of ligament injuries in sports.

Market Concentration & Characteristics

The muscle stimulator market exhibits moderate industry concentration, with several key players dominating the market. Initiatives to raise awareness of muscle weakness & poor motor control, and treatment options further stimulate market growth. Overall, the market is dynamic, driven by innovations to improve the efficiency and effectiveness of stimulators and therapies while prioritizing patient well-being.

The muscle stimulator industry is characterized by a high degree of innovation, with companies consistently developing products that advance electrotherapy and neuromodulation technologies. These innovations enable manufacturers to develop more compact, portable, and user-friendly devices that cater to an increasingly diverse range of applications. For instance, in July 2023, Motive Health, Inc. launched Motive Knee, a muscle stimulation device for knee pain.IT is an over-the-counter electrical muscle stimulator that helps in relieving pain associated with knee arthritis.

Compliance with regulatory requirements, such as The Food and Drug Administration (FDA), which regulates electrical muscle stimulators under the Federal Food, Drug, and Cosmetic Act. The FDA is responsible for ensuring that EMS devices are safe and effective for their intended uses. Most EMS devices intended for use in physical therapy and rehabilitation require a prescription from a healthcare professional. If a company wants to sell EMS devices directly to consumers, it must demonstrate that the device can be used safely and effectively in that setting. The FDA is concerned about the unregulated marketing of these devices because they may not comply with electrical safety standards, posing a risk of electrocution to users and other household members, including children. The agency is currently investigating firms that are illegally marketing EMS devices.

Mergers and acquisitions in the muscle stimulator industry are rising due to the need for research and development, reflecting the industry's dynamic nature. Companies are leveraging M&A activities to innovate and offer advanced solutions that meet the evolving needs of healthcare professionals. For instance, in May 2025, electroCore, Inc. announced the completion of its acquisition of NeuroMetrix, Inc. This acquisition enabled electroCore to integrate the Quell Fibromyalgia device into its portfolio, significantly expanding its presence in chronic pain management and non-invasive nerve stimulation technologies. The deal also enhanced electroCore’s commercial reach and diversified its bioelectronic therapy solutions.

The muscle stimulator industry is experiencing robust global expansion due to increasing healthcare expenditure, technological advancements, and growing demand for muscle stimulator devices. Regional expansion in the muscle stimulator industry involves penetrating new geographical markets to broaden the customer base and increase market share. For instance, in March 2025, Zynex, Inc. expanded its electrotherapy device distribution across the U.S., particularly in outpatient rehabilitation centers and home healthcare settings. This expansion aims to increase accessibility of its muscle stimulation and pain management devices, especially in underserved regions, thereby enhancing patient reach and market penetration.

Product Insights

The transcutaneous electrical nerve stimulation (TENS) segment held the largest market share of 67.0% in 2025. The growing prevalence of arthritis and increasing sports injuries are prominent factors augmenting the market growth. A study published by the Institute for Health Metrics and Evaluation in August 2023 highlights that approximately 1 billion people are projected to live with osteoarthritis (OA), the most prevalent form of arthritis, by the year 2050. Osteoarthritis, a degenerative joint disease, predominantly affects the knees and hands. According to the Centers for Disease Control and Prevention (CDC), by 2050, the prevalence of knee osteoarthritis is projected to increase by 75%, while hand osteoarthritis is anticipated to rise by 50%.

Burst mode alternating current (BMAC) is expected to be the fastest-growing segment during the forecast period. BMAC provides more efficient muscle stimulation than traditional constant current (CC) or pulsed current (PC) methods. BMAC has been shown to improve clinical outcomes across applications, such as pain management, muscle rehabilitation, and athletic performance enhancement. For instance, studies have demonstrated that BMAC can significantly reduce pain and improve the range of motion in patients with chronic low back pain. In addition, research suggests that BMAC may enhance muscle strength and endurance more effectively than CC or PC stimulation in healthy individuals.

Modality Insights

The portable devices segment dominated the market in 2025 and is estimated to witness the fastest CAGR of 3.4% during the forecast period. Portable muscle stimulators are used extensively to prevent muscle atrophy, relieve muscle spasms, manage chronic pain due to arthritis, and increase blood circulation. Moreover, many key players in the market are offering a range of innovative stimulators in this segment. For instance, in February 2026, Zynex, Inc. highlighted the growing adoption of its NexWave device, a portable electrotherapy system designed for at-home use, reinforcing the increasing demand for portable and user-friendly pain management solutions.

The handheld stimulators segment is driven by increasing demand for compact, easy-to-use, and clinically effective devices for pain management and rehabilitation. These devices are preferred by both healthcare professionals and patients due to their convenience and ability to deliver targeted therapy for muscle recovery and pain relief. Handheld stimulators are particularly beneficial in outpatient and home-care settings, as they enable continuous therapy without requiring extensive clinical supervision. For instance, in September 2024, Zynex received FDA approval for the TensWave device, built on Zynex's strong legacy of innovation in pain management. It offers a user-friendly, portable design that can be easily integrated into patients' daily routines. The device aims to provide effective pain relief through TENS (Transcutaneous Electrical Nerve Stimulation), a therapy clinically proven to reduce both acute and chronic pain without medication.

Application Insights

The pain management segment dominated the market in 2025 and is anticipated to grow at the fastest CAGR over the forecast period. The aging population is a significant driver for the pain management segment. With an increasing number of older adults experiencing chronic pain, there is a growing demand for safe and efficient pain management solutions. For instance, according to a 2024 report published by the Centers for Disease Control and Prevention (CDC), 24.3% of U.S. adults were experiencing chronic pain, while 8.5% suffered from high-impact chronic pain, with prevalence increasing significantly with age.

The musculoskeletal disorder segment is expected to grow significantly over the forecast period. The rising prevalence of musculoskeletal disorders among citizens is expected to further drive market growth. Poor body posture, lack of fitness activities, and unhealthy diet habits are common factors causing musculoskeletal disorders. The 2023 HSE Report highlights that approximately 473,000 workers in Great Britain experienced work-related musculoskeletal disorders (MSDs), resulting in the loss of around 6.6 million working days. These disorders accounted for 27% of all work-related ill health cases.

End Use Insights

The physiotherapy clinics segment dominated the market with the largest revenue share in 2025 and is anticipated to witness the fastest CAGR during the forecast period. The growing preference of physiotherapists toward stimulators as compared to manual techniques is a major factor driving the growth of this segment. On the other hand, increasing patient visits for seeking stimulation therapies and the availability of these therapies at an affordable cost at physiotherapy clinics are the major factors anticipated to drive the market growth. For instance, in March 2026, a report published by the World Health Organization highlighted that musculoskeletal conditions remain one of the leading causes of disability globally, significantly increasing the demand for physiotherapy and rehabilitation services across clinical settings.

The sports clinics segment held the second-largest revenue share in 2025. The growth is attributed to the growing number of athletes seeking to optimize their performance and recover from injuries more effectively. Moreover, professional organizations and governing bodies within the sports industry are recognizing the value of EMS therapy in enhancing athlete performance and injury management. For instance, the National Athletic Trainers’ Association (NATA) has included electrical modality treatments, such as muscle stimulation, in its evidence-based practice guidelines for managing various athletic injuries.

Regional Insights

North America muscle stimulator industry dominated the overall global market and accounted for the 41.1% revenue share in 2025. The presence of key participants, large investments by governments for innovation & development of medical devices, and the early introduction of novel muscle stimulators supplement the region's growth. Moreover, the high purchasing power of consumers and the increased adoption of advanced technologies & innovative medical devices are expected to further drive growth.

In addition, the increasing adoption of non-invasive and drug-free pain management solutions is driving the market in the North American region. Many individuals are seeking alternatives to medication or invasive procedures for pain relief. Muscle stimulators provide a non-pharmacological approach to managing pain and discomfort, making them appealing to a wide range of consumers in the region.

U.S. Muscle Stimulator Market Trends

Themuscle stimulator industry in the U.S. held a significant share of the North Americamarket in 2025, driven by the growing product approvals in the country. For instance, in January 2024, electronic muscle stimulators received U.S. FDA approval for use in strengthening, tightening, and toning core muscles. These devices are commonly employed in physical therapy or rehabilitation settings. Doctors often prescribe electronic muscle stimulators for various conditions, such as muscle spasms, to improve range of motion, prevent muscle atrophy, and aid in muscle recovery following significant injuries or major surgeries.

Europe Muscle Stimulator Market Trends

Themuscle stimulator industry in Europeis witnessing growth driven by the increasing prevalence of musculoskeletal disorders and sports-related injuries. For instance, in November 2025, a clinical study conducted on professional football players in Europe reported that advanced rehabilitation therapies, including stimulation-based treatments, were integrated into injury recovery programs during the 2024–2025 season, supporting faster recovery and improved clinical outcomes among athletes.

The UK muscle stimulator industry is expected to grow significantly over the forecast period, owing to the increasing prevalence of musculoskeletal disorders. For instance, 2024 to 25 data published in 2025 by the Health and Safety Executive highlights approximately 511,000 workers in Great Britain were suffering from work-related musculoskeletal disorders, while around 7.1 million working days were lost due to these conditions, highlighting the continued burden of musculoskeletal issues across the workforce.

The muscle stimulator industry in Germany is expected to grow significantly over the forecast period due to the rising regulatory approvals and reimbursement policies. In February 2026, Germany’s Federal Institute for Drugs and Medical Devices (BfArM) highlighted that over 60 digital health applications (DiGAs) are now approved and reimbursed under the statutory health insurance (SHI) system, enabling physicians to prescribe digital and device-based therapies for rehabilitation and chronic condition management.

Asia PacificMuscle Stimulator Market Trends

The muscle stimulator industry in the Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. China and Japan are poised to lead the Asia Pacific market in the near term. Moreover, the availability of trained professionals and the presence of developing healthcare facilities are expected to drive market growth over the forecast period. Moreover, growing awareness related to health and fitness, increasing adoption of pain management therapies, and rising usage of smart devices for maintaining health are the key growth stimulants of the region. Moreover, increasing sports injuries in this region are poised to stir the demand for muscle stimulators during the forecast period.

The China muscle stimulator industry is expected to grow robustly. The expanding healthcare infrastructure, growing healthcare workforce, and well-established medical facilities in China are anticipated to drive market expansion in the future. For instance, in May 2025, Mindray highlighted its continued expansion in rehabilitation and patient monitoring solutions across hospitals and clinical settings in China, supporting the integration of advanced medical technologies, including electrotherapy and rehabilitation devices, into routine care.

The muscle stimulator industry in India is expected to grow significantly, driven by the rapid expansion of healthcare infrastructure, increasing adoption of rehabilitation therapies, and rising demand for non-invasive pain management solutions. For instance, in September 2025, GIMS launched an advanced center for pain and sports injury care, equipped with technologies such as high-energy inductive therapy, laser therapy, and compression therapy systems for rehabilitation and pain management. This development highlights the growing integration of advanced physiotherapy and stimulation-based treatments in clinical settings across India.

Latin America Muscle Stimulator Market Trends

The muscle stimulator industry in Latin America is driven by awareness of women's health, rise in healthcare spending, and infrastructural investments.Moreover, the increasing prevalence of musculoskeletal disorders and sports injuries creates a growing demand for non-invasive rehabilitation and pain management solutions. The rising awareness about the benefits of muscle stimulation therapy among athletes, fitness enthusiasts, and aging populations fuels market growth. Technological advancements leading to the development of portable, wireless, and customizable devices further stimulate market demand.

The Brazil muscle stimulator industry is expected to grow on the back of technological advancements, leading to the development of portable, wireless, and customizable muscle stimulation devices that enable users to incorporate muscle stimulation into their daily routines conveniently. The government initiatives to expand access to healthcare services and invest in medical technology further support the growth of the Brazilian market.

Middle East & Africa Muscle Stimulator Market Trends

The muscle stimulator industry in MEAis driven by the rising awareness about health and fitness among consumers in both regions. Muscle stimulators are increasingly being used for bodybuilding, athletic training, and rehabilitation purposes to enhance muscle strength, tone, and endurance. Furthermore, governments in Middle Eastern countries such as Saudi Arabia and the UAE are investing heavily in healthcare infrastructure development, which is expected to create new opportunities for muscle stimulator manufacturers.

The Saudi Arabia muscle stimulator industry is anticipated to grow significantly over the forecast period, driven by the country’s increasing focus on advanced healthcare delivery and rehabilitation services under its healthcare transformation initiatives. The growing emphasis on improving the quality of care, expanding specialized treatment centers, and adopting modern medical technologies is expected to support market growth. For instance, in 2025, the Ministry of Health in Saudi Arabia announced continued expansion of rehabilitation and physiotherapy services across public healthcare facilities as part of Vision 2030 healthcare reforms, with a focus on enhancing access to advanced treatment technologies for pain management and recovery.

Key Muscle Stimulator Company Insights

The competitive scenario in the muscle stimulator market is highly competitive, with key players. The major companies are undertaking various organic as well as inorganic strategies, such as new product development, collaborations, acquisitions, mergers, and regional expansion, to serve the unmet needs of their customers. 

Recent Developments

• In February 2026, Zynex, Inc. announced that it had secured in-network provider status with Humana, expanding patient access to its NexWave electrotherapy device for pain management and rehabilitation. The NexWave system integrates TENS, NMES, and IFC modalities, supporting non-invasive treatment for chronic pain and neuromuscular conditions.

• In March 2025, OMRON Healthcare expanded its portfolio of portable TENS therapy devices, emphasizing compact, user-friendly electrotherapy solutions for muscle pain relief and rehabilitation. These devices are designed for home use and support the growing demand for non-invasive pain management technologies.

• In December 2025, Longest Medical announced that its LGT-2320 series electrotherapy devices received FDA clearance, validating their safety and effectiveness for rehabilitation and pain management applications. The system supports multiple electrotherapy modalities and is designed for clinical use in muscle stimulation and recovery.

•  In November 2025, Motive Health, Inc. received FDA 510(k) clearance for its Motive Muscle Stimulator for Lower Back, a home-use neuromuscular electrical stimulation (NMES) device designed to stimulate muscles and improve performance through controlled contractions. The system uses wireless, app-based control and delivers non-invasive electrotherapy for muscle strengthening.

Muscle Stimulator Market Report Scope

Global Muscle Stimulator Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global muscle stimulator market report on the basis of product, modality, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Neuromuscular Electrical Stimulation

  • Functional Electrical Stimulation

  • Transcutaneous Electrical Nerve Stimulation

  • Interferential

  • Burst Mode Alternating Current

  • Micro Current Electrical Neuromuscular Stimulator

  • Others

• Modality Outlook (Revenue, USD Million, 2021 - 2033)

  • Handheld

  • Portable

  • Tabletop

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Pain management

  • Neurological disorder

  • Musculoskeletal disorder

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Ambulatory surgical centers

  • Physiotherapy clinics

  • Sports clinics

  • Home care

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait